Nesvategrast

N/A

Report date: 2025/12/15 13:07:20

Base Information

Drug NameNesvategrast
Drug Alias NameSF-0166OTT-166(OcuTerra Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-6 inhibitorsintegrin alpha V/beta 8 inhibitorsIntegrin alpha-V/beta-3 inhibitors
TargetsIntegrin alpha-V/beta-3Integrin alpha-V/beta-6integrin alpha V/beta 8
Therapy Area/IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesScifluor Life Sciences IncOcuTerra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOcuTerra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsDiabetic macular oedemaMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A